Show simple item record

dc.creatorUl Amin Mohsin, Noor
dc.creatorAhmed, Matloob
dc.creatorIrfan, Muhammad
dc.date2019-10-30
dc.date.accessioned2019-11-13T15:11:55Z
dc.date.available2019-11-13T15:11:55Z
dc.identifierhttp://www.jcchems.com/index.php/JCCHEMS/article/view/1314
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/112774
dc.descriptionZidovudine was the first drug approved for the treatment of Acquired Immuno Deficiency Syndrome (AIDS). Its chemical name is azidothymidine (AZT). AZTuse is associated with bone marrow toxicity. Shorter half-life and inability to penetrate the blood-brain barrier are the pharmacokinetic problems of this importantdrug molecule. Various modifications have been carried out in the structure of AZT. These include modification of hydroxyl and azido group, thymidine ring,preparation of phosphate and phosphonate derivatives, attachment of polymers and synthesis of hybrid molecules. Some of these changes produced compounds withsignificantly increased activity and less toxicity. This review highlights the various structural modifications of AZT and their influence on biological activities andpharmacokinetic properties.en-US
dc.formatapplication/pdf
dc.languageeng
dc.publisherSociedad Chilena de Químicaen-US
dc.relationhttp://www.jcchems.com/index.php/JCCHEMS/article/view/1314/329
dc.sourceJournal of the Chilean Chemical Society; Vol 64 No 3 (2019): Journal of the Chilean Chemical Society; 4523-4530en-US
dc.source0717-9707
dc.source0717-9324
dc.subjectHuman Immunodeficiency Virus (HIV)en-US
dc.subjectHybridsen-US
dc.subjectPhosphate and phosphonateen-US
dc.subjectPolymersen-US
dc.subjectProdrugsen-US
dc.titleZIDOVUDINE: STRUCTURAL MODIFICATIONS AND THEIR IMPACT ON BIOLOGICAL ACTIVITIES AND PHARMACOKINETIC PROPERTIESen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


This item appears in the following Collection(s)

Show simple item record